You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality

Article metrics

Article menu

Download PDFPDF

XML
Oncolytic and local immunotherapy
Original research
Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality

 

Online download statistics by month:

Online download statistics by month: March 2020 to January 2026

AbstractFullPdf
Mar 2020036489
Apr 2020016153
May 202009233
Jun 202005436
Jul 202008418
Aug 202006313
Sep 202005011
Oct 202004719
Nov 202004419
Dec 20200437
Jan 202107530
Feb 202107117
Mar 202107424
Apr 202104418
May 202102915
Jun 20210367
Jul 202107444
Aug 202104225
Sep 202103618
Oct 202105941
Nov 202106120
Dec 202107224
Jan 202204816
Feb 20220268
Mar 202206525
Apr 202206320
May 202203715
Jun 202204311
Jul 202205529
Aug 202205214
Sep 202206421
Oct 202206927
Nov 202204429
Dec 202203713
Jan 202303637
Feb 202308737
Mar 202304826
Apr 202303418
May 202304022
Jun 202303913
Jul 202306119
Aug 202302810
Sep 202304211
Oct 202302511
Nov 202303816
Dec 202303515
Jan 202402410
Feb 202405020
Mar 202402374
Apr 202404122
May 202403812
Jun 202404212
Jul 202404221
Aug 20240347
Sep 202402416
Oct 202404820
Nov 202404915
Dec 202406814
Jan 202507522
Feb 2025011614
Mar 202505414
Apr 202507525
May 202504312
Jun 202503418
Jul 2025010
Aug 2025010
Jan 2026010
Total036741392